AI MARKET SCANNING

$ONCIN.OL

🔒 Europe

Oncoinvent ASA

🏛️ EURONEXT OSLO 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP -2.60%
MAX GAP RECORD -6.08%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $ONCIN.OL
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 27, 2026 Earnings Release 2026-08-27 (AFTER CLOSE)
+0.88%
Feb 26, 2026 Earnings Release 2026-02-26 (BEFORE OPEN)
-6.08%

VOLATILITY & GAP BIAS

AVG GAP MOVE 3.5%
Bullish Gaps (0)
Bearish Gaps (1)
Neutral / Flat (1)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $ONCIN.OL

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Oncoinvent ASA operates as a clinical-phase biotechnology company, which engages in the development of radiopharmaceutical treatment products for cancer therapy. Its focus product is Radspherin, which uses the alpha-emitting radionuclide radium-224 that targets residual micrometastases after surgery in the abdominal cavity. The company was founded by Roy H. Larsen, Øyvind…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗